5 Best Vaccine Stocks to Buy Now

Page 1 of 5

In this article we will take a look at the 5 best vaccine stocks to buy now. For a detailed analysis of the biopharma industry, go directly to the 10 Best Vaccine Stocks to Buy Now.


Number of Hedge Fund Holders: 17

BioNTech SE (NASDAQ: BNTX) is a Germany-based biotechnology firm that makes active immunotherapies for patient-specific approaches to the treatment of several diseases, including cancer. The firm is developing drugs for advanced melanoma, prostate cancer, head and neck cancers, triple negative breast cancer, ovarian cancer, and lung cancer. It also makes drugs for treating solid tumors. The company was founded in 2008 and is placed fifth on our list of 10 best vaccine stocks to buy now.

BioNTech has collaborations with Genentech, Sanofi, Shanghai Fosun Pharmaceutical, and Regeneron Pharmaceuticals. On April 18, the company announced that it would provide 100 million more doses of the COVID-19 vaccine it had developed to the European Union. Out of the hedge funds being tracked by Insider Monkey, San Francisco-based investment firm Redmile Group held the most shares – 580,746 – worth more than $47 million. Ikarian Capital was 2nd with more than 319,900 shares worth almost $26 million.


Page 1 of 5